OpenBilldrug price receipt

NADAC week of 2026-10-14

ALLOPURINOL 100 MG TABLET

For 30 tablets

Pharmacies pay

$0.95 filed

30 × $0.03154 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$3.86 filed

30 × $0.12863 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.1× estimated

Medicare paid 4.1× what pharmacies pay.

Part D averages every strength and form sold under “Allopurinol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.09 estimated

$0.95 + $0.14 (15%) + $5.00 fee per fill = $6.09

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ALLOPURINOL 100 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as allopurinol.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 18 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Actavis Pharma, Inc. and Par Health USA, LLC.

FDA’s Established Pharmacologic Class for it is Xanthine Oxidase Inhibitor.

The NADAC file of 2026-10-14 prices it under 40 NDCs (National Drug Codes); the FDA directory lists 38 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.95 for 30 tablets (30 × $0.03154 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 18 labelers

LabelerNDCsPharmacies pay per unit
NorthStar RxLLC4$0.03154 per EA filed
Camber Pharmaceuticals, Inc.3$0.03154 per EA filed
Florida Pharmaceutical Products, LLC3$0.03154 per EA filed
Leading Pharma, LLC3$0.03154 per EA filed
Sun Pharmaceutical Industries, Inc.3$0.03154 per EA filed
Aurobindo Pharma Limited2$0.03154 per EA filed
Chartwell RX, LLC2$0.03154 per EA filed
Dr. Reddy's Laboratories Limited2$0.03154 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2$0.03154 per EA filed
Mylan Pharmaceuticals Inc.2$0.03154 per EA filed
Par Health USA, LLC2$0.03154 per EA filed
Rising Pharma Holdings, Inc.2$0.03154 per EA filed
Unichem Pharmaceuticals (USA), Inc.2$0.03154 per EA filed
Zydus Pharmaceuticals (USA) Inc.2$0.03154 per EA filed
Actavis Pharma, Inc.1$0.03154 per EA filed
American Health Packaging1$0.03154 per EA filed
Major Pharmaceuticals1$0.03154 per EA filed
Mylan Institutional Inc.1$0.03154 per EA filed
Not listed as a package in the FDA directory2$0.03154 per EA filed
All 40 NDCs, with labeler and price
  • 00378-0137-01 · Mylan Pharmaceuticals Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 00378-0137-10 · Mylan Pharmaceuticals Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 00591-5543-10 · Actavis Pharma, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 00603-2115-21 · Par Health USA, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 00603-2115-32 · Par Health USA, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 00904-7041-61 · Major Pharmaceuticals · $0.03154 per EA · eff. 2026-09-23 filed
  • 16571-0883-09 · Rising Pharma Holdings, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 16571-0883-10 · Rising Pharma Holdings, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 16714-0576-01 · NorthStar RxLLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 16714-0576-02 · NorthStar RxLLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 16714-0576-03 · NorthStar RxLLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 16714-0576-04 · NorthStar RxLLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 23155-0693-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 23155-0693-10 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 29300-0349-01 · Unichem Pharmaceuticals (USA), Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 29300-0349-05 · Unichem Pharmaceuticals (USA), Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 31722-0252-01 · Camber Pharmaceuticals, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 31722-0252-05 · Camber Pharmaceuticals, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 31722-0252-10 · Camber Pharmaceuticals, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 51079-0205-01 · not listed as a package in the FDA directory · $0.03154 per EA · eff. 2026-09-23 filed
  • 51079-0205-20 · Mylan Institutional Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 53489-0156-01 · Sun Pharmaceutical Industries, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 53489-0156-05 · Sun Pharmaceutical Industries, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 53489-0156-10 · Sun Pharmaceutical Industries, Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 55111-0729-01 · Dr. Reddy's Laboratories Limited · $0.03154 per EA · eff. 2026-09-23 filed
  • 55111-0729-10 · Dr. Reddy's Laboratories Limited · $0.03154 per EA · eff. 2026-09-23 filed
  • 59651-0285-01 · Aurobindo Pharma Limited · $0.03154 per EA · eff. 2026-09-23 filed
  • 59651-0285-99 · Aurobindo Pharma Limited · $0.03154 per EA · eff. 2026-09-23 filed
  • 60687-0677-01 · American Health Packaging · $0.03154 per EA · eff. 2026-09-23 filed
  • 60687-0677-11 · not listed as a package in the FDA directory · $0.03154 per EA · eff. 2026-09-23 filed
  • 62135-0516-31 · Chartwell RX, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 62135-0516-90 · Chartwell RX, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 69315-0291-01 · Leading Pharma, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 69315-0291-05 · Leading Pharma, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 69315-0291-10 · Leading Pharma, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 70710-1209-00 · Zydus Pharmaceuticals (USA) Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 70710-1209-01 · Zydus Pharmaceuticals (USA) Inc. · $0.03154 per EA · eff. 2026-09-23 filed
  • 71921-0240-01 · Florida Pharmaceutical Products, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 71921-0240-50 · Florida Pharmaceutical Products, LLC · $0.03154 per EA · eff. 2026-09-23 filed
  • 71921-0240-60 · Florida Pharmaceutical Products, LLC · $0.03154 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name allopurinol with ALLOPURINOL 100 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ALLOPURINOL 100 MG TABLET this page
generic · tablet
$0.03154 per EA filed
eff. 2026-09-23
$0.12863 per EA filed
Part D 2024 average
ALLOPURINOL 200 MG TABLET
generic · tablet
$1.84028 per EA filed
eff. 2026-09-23
$0.12863 per EA filed
Part D 2024 average
ALLOPURINOL 300 MG TABLET
generic · tablet
$0.05218 per EA filed
eff. 2026-09-23
$0.12863 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 40 NDCs’ NADAC prices is $0.03154 per EA filed.

Of the 6 other products in FDA’s Xanthine Oxidase Inhibitor class priced per EA, 6 have a higher middle NADAC price and 0 a lower one. The one in the middle is FEBUXOSTAT 80 MG TABLET, at $0.26104 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $3.86 for 30 tablets, at an average of $0.12863 per EA in 2024 (2024-01-01 to 2024-12-31) for “Allopurinol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 9,710,041 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ALLOPURINOL 100 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Allopurinol / Allopurinol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.